Estimated value and 95% confidence interval of the excess relative risk per 1Sv
by malignancy site(1958-1987)
•
At each malignant tumor site, excess relative risk was estimated on the basis of the gamma ray dose or the organ dose using the 1986 dosimetry system (DS86).
•
A significantly high excess relative risk was recognized in leukemia, malignant tumors of the stomach, colon, lung, breast, ovary, bladder, thyroid and liver, and skin cancer other than melanoma.
•
The snalysis of tumors as a whole did not reveal a significant difference between Nagasaki and Hiroshima.
[Cited and modified from Thompson DE, et al., Radiat Res 137:S17-S67, 1994]
